Nxera Pharma Cash from Investing (TTM) Insights

Nxera Pharma Co Ltd (SOLTF)

8.92 -0.80 (-8.27%) USD | OTCM | May 21, 16:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
March 31, 2024	-454.02M
December 31, 2023	-454.67M
September 30, 2023	-427.28M
June 30, 2023	-3.357M
March 31, 2023	7.789M
December 31, 2022	7.999M
September 30, 2022	-1.373M
June 30, 2022	-2.624M
March 31, 2022	2.344M
December 31, 2021	2.534M
September 30, 2021	3.065M
June 30, 2021	5.937M
March 31, 2021	-3.809M
December 31, 2020	-1.405M
September 30, 2020	-1.280M
June 30, 2020	-3.069M
March 31, 2020	1.477M
December 31, 2019	-2.257M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018	-27.11M
June 30, 2018	-17.88M
March 31, 2018	-55.49M

Date	Value
December 31, 2017	-53.41M
September 30, 2017	-65.05M
June 30, 2017	-66.85M
March 31, 2017	-21.52M
December 31, 2016	-19.48M
September 30, 2016	-3.949M
June 30, 2016	-3.350M
March 31, 2016	-2.808M
December 31, 2015	-199.72M
September 30, 2015	-201.04M
June 30, 2015	-201.22M
March 31, 2015	-201.34M
December 31, 2014	-4.863M
September 30, 2014	-3.380M
June 30, 2014	-3.291M
March 31, 2014	-3.147M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-454.67M

Minimum

Dec 2023

7.999M

Maximum

Dec 2022

-73.56M

Average

-1.389M

Median

Cash from Investing (TTM) Benchmarks